10.84
price up icon4.69%   0.485
after-market Dopo l'orario di chiusura: 10.50 -0.335 -3.09%
loading
Precedente Chiudi:
$10.35
Aprire:
$10.38
Volume 24 ore:
117.53K
Relative Volume:
0.09
Capitalizzazione di mercato:
$86.20M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-16.67
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
+8.79%
1M Prestazione:
+34.10%
6M Prestazione:
+31.81%
1 anno Prestazione:
-42.37%
Intervallo 1D:
Value
$9.83
$11.00
Intervallo di 1 settimana:
Value
$9.8101
$11.00
Portata 52W:
Value
$3.436
$20.40

Biodesix Inc Stock (BDSX) Company Profile

Name
Nome
Biodesix Inc
Name
Telefono
303-417-0500
Name
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Name
Dipendente
273
Name
Cinguettio
Name
Prossima data di guadagno
2025-10-31
Name
Ultimi documenti SEC
Name
BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, IDXX, A, WAT

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
BDSX
Biodesix Inc
10.84 82.34M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
509.82 198.06B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
214.94 155.50B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
617.20 51.80B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
124.88 36.46B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
319.83 32.29B 3.17B 642.63M 539.81M 10.77

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-14 Downgrade William Blair Outperform → Mkt Perform
2024-09-16 Iniziato Scotiabank Sector Outperform
2024-07-26 Iniziato Craig Hallum Buy
2024-05-13 Iniziato TD Cowen Buy
2024-05-03 Iniziato Lake Street Buy
2021-11-17 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-11-23 Iniziato BTIG Research Buy
2020-11-23 Iniziato Canaccord Genuity Buy
2020-11-23 Iniziato Morgan Stanley Overweight
2020-11-23 Iniziato William Blair Outperform
Mostra tutto

Biodesix Inc Borsa (BDSX) Ultime notizie

pulisher
Feb 12, 2026

Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 48.4% - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Biodesix, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative

Feb 12, 2026
pulisher
Feb 12, 2026

Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times

Feb 12, 2026
pulisher
Feb 11, 2026

Biodesix (NASDAQ:BDSX) CEO Scott Hutton Sells 3,559 Shares - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

What is Biodesix Inc. s 5 year growth outlookQuarterly Investment Review & AI Based Buy and Sell Signals - mfd.ru

Feb 10, 2026
pulisher
Feb 10, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Feb 10, 2026
pulisher
Feb 03, 2026

Can Biodesix Sustain Its Growth Momentum In 2026? - RTTNews

Feb 03, 2026
pulisher
Jan 30, 2026

Telemark Asset Management, LLC Increases Stake in Biodesix Inc - GuruFocus

Jan 30, 2026
pulisher
Jan 28, 2026

What is the dividend yield of Biodesix IncWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 82,465 Shares - Defense World

Jan 28, 2026
pulisher
Jan 28, 2026

Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Increases By 499.1% - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Hedge Fund and Insider Trading News: Seth Klarman, Dan Loeb, Michael Burry, Michael Platt, Bridgewater Associates, Greenlight Capital, Biodesix Inc (BDSX), UWM Holdings Corp (UWMC), and More - Insider Monkey

Jan 27, 2026
pulisher
Jan 27, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 80,000 Shares - MarketBeat

Jan 27, 2026
pulisher
Jan 27, 2026

Biodesix (NASDAQ:BDSX) Director Acquires $236,000.00 in Stock - MarketBeat

Jan 27, 2026
pulisher
Jan 27, 2026

Biodesix director Schuler buys $1.1m+ in BDSX stock By Investing.com - Investing.com South Africa

Jan 27, 2026
pulisher
Jan 27, 2026

Biodesix director Schuler buys $1.1m+ in BDSX stock - Investing.com

Jan 27, 2026
pulisher
Jan 26, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 82,465 Shares - MarketBeat

Jan 26, 2026
pulisher
Jan 26, 2026

Biodesix (BDSX) emeritus director Schuler buys $903k in stock By Investing.com - Investing.com Nigeria

Jan 26, 2026
pulisher
Jan 26, 2026

Biodesix (BDSX) emeritus director Schuler buys $903k in stock - Investing.com

Jan 26, 2026
pulisher
Jan 26, 2026

Perkins Capital Management Inc. Has $397,000 Position in Biodesix, Inc. $BDSX - MarketBeat

Jan 26, 2026
pulisher
Jan 25, 2026

Big Money Moves: Can Biodesix Inc expand into new marketsTrade Risk Summary & Entry Point Confirmation Signals - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 21, 2026

Reviewing Biodesix (NASDAQ:BDSX) and HealthEquity (NASDAQ:HQY) - Defense World

Jan 21, 2026
pulisher
Jan 19, 2026

How geopolitical tensions affect Biodesix Inc. stockWeekly Trade Review & High Accuracy Investment Entry Signals - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

BDSX stock shot up 23% pre-market today — what’s fueling the surge? - MSN

Jan 18, 2026
pulisher
Jan 16, 2026

Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 16, 2026
pulisher
Jan 16, 2026

Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 16, 2026
pulisher
Jan 15, 2026

Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - Sahm

Jan 15, 2026
pulisher
Jan 13, 2026

Biodesix stock soars as preliminary results exceed guidance, achieves EBITDA profitability - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 13, 2026

Quarterly Trades: Will Biodesix Inc stock rally after Fed decisions2025 Market Overview & Growth Focused Entry Point Reports - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Biodesix: Strengthening Fundamentals, Emerging Profitability, and Strategic Growth Support Buy Rating and $20 Price Target - TipRanks

Jan 13, 2026
pulisher
Jan 13, 2026

Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN

Jan 13, 2026
pulisher
Jan 13, 2026

Biodesix: Strong Operational Momentum but Ongoing Capital Concerns Justify Hold Rating - TipRanks

Jan 13, 2026
pulisher
Jan 13, 2026

Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance By Investing.com - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 12, 2026

Biodesix sees stock soar after surpassing sales guidance - BizWest

Jan 12, 2026
pulisher
Jan 12, 2026

BDSX Faces Financial Hurdles as Stock Volatility Heightens - StocksToTrade

Jan 12, 2026
pulisher
Jan 12, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Jan 12, 2026
pulisher
Jan 12, 2026

Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability - FinancialContent

Jan 12, 2026
pulisher
Jan 12, 2026

BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? - Asianet Newsable

Jan 12, 2026
pulisher
Jan 12, 2026

Biodesix Stock Rebounds on Strategic Plans for Market Expansion - timothysykes.com

Jan 12, 2026
pulisher
Jan 12, 2026

This Diagnostics Stock Is Surging 23% Pre-Market Today – Here’s Why - Stocktwits

Jan 12, 2026
pulisher
Jan 12, 2026

Biodesix (BDSX) Surges 41% on Strong Preliminary Q4 and FY Resul - GuruFocus

Jan 12, 2026
pulisher
Jan 12, 2026

Biodesix Surges On Strong Preliminary Q4 And FY2025 Revenue Results - Nasdaq

Jan 12, 2026

Biodesix Inc Azioni (BDSX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$206.86
price down icon 1.18%
diagnostics_research LH
$278.11
price down icon 4.06%
diagnostics_research MTD
$1,357.92
price down icon 2.49%
diagnostics_research IQV
$168.85
price down icon 4.70%
$207.84
price down icon 2.18%
diagnostics_research WAT
$319.83
price down icon 2.85%
Capitalizzazione:     |  Volume (24 ore):